InfuSystem Holdings (INFU) Gross Margin (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Gross Margin came in at 58.43% in Q1 2026, up 322.0% YoY from 13.85% in Q1 2025, and up 3.6% on a QoQ basis from 56.4% in Q4 2025.
InfuSystem Holdings (INFU) Gross Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Gross Margin data on file, last reported at 58.43% in Q1 2026.
- Quarterly Gross Margin rose 322.0% year-over-year to 58.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56.75% (up 362.0% YoY) and the FY2025 annual result came in at 55.98%, up 378.0% from the prior year.
- Gross Margin grew to 58.43% in Q1 2026, from 56.4% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 59.46% in Q3 2022 to a low of 48.81% in Q4 2022.
- A 5-year average of 53.67% and a median of 53.92% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin sank 1052 bps — and 2025, when it soared 574 bps.
- Tracing INFU's Gross Margin over 5 years: stood at 48.81% in 2022, then climbed by 8 bps to 52.6% in 2023, then gained by 2 bps to 53.82% in 2024, then grew by 5 bps to 56.4% in 2025, then climbed by 4 bps to 58.43% in 2026.
- The last three Gross Margin figures came in at 58.43% (Q1 2026), 56.4% (Q4 2025), and 57.06% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.84% |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 57.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.98% |
| Mar 31, 2026 | 58.43% |
| Dec 31, 2025 | 56.40% |
| Sep 30, 2025 | 57.06% |
| Jun 30, 2025 | 55.20% |
| Mar 31, 2025 | 55.21% |
| Dec 31, 2024 | 53.82% |
| Sep 30, 2024 | 53.92% |
| Jun 30, 2024 | 49.46% |
| Mar 31, 2024 | 51.49% |
| Dec 31, 2023 | 52.60% |
| Sep 30, 2023 | 48.94% |
| Jun 30, 2023 | 49.89% |
| Mar 31, 2023 | 49.23% |
| Dec 31, 2022 | 48.81% |
| Sep 30, 2022 | 59.46% |
| Jun 30, 2022 | 55.10% |
| Mar 31, 2022 | 57.42% |
| Dec 31, 2021 | 51.45% |
| Sep 30, 2021 | 57.43% |